✦ LIBER ✦

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Mark A. Morgan; Michael W. Sill; Keiichi Fujiwara; Benjamin Greer; Stephen C. Rubin; Koen DeGeest; S. Diane Yamada; Steven Waggoner; Robert L. Coleman; Joan L. Walker; Robert S. Mannel

Book ID: 113963077
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 172 KB
Volume: 121
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.12.358

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; P.H. Thaker; Paul DiSilvestro; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase I study with an expanded cohort

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

✍ Natalie Gould; Michael W. Sill; Robert S. Mannel; Premal H. Thaker; Paul A. DiSi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase I feasibility study of intraperito

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Paclitaxel, carboplatin and pegylated li

Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A phase I study of the Gynecologic Oncology Group

✍ Peter G. Rose; Benjamin E. Greer; Ira R. Horowitz; Maurie Markman; Nancy Fusco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Paclitaxel poliglumex and carboplatin as

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group

✍ Mark A. Morgan; Kathleen M. Darcy; Peter G. Rose; Koen DeGeest; Michael A. Bookm 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 164 KB